ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 890

$1.49M Total Retail Price of All Prescriptions

Rank: 10 out of 890

350 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 350 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

25% of this provider’s 350 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 21,774 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

67 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 884 867 1 7
LEVOTHYROXINE SODIUM 665 613 2 2
WARFARIN SODIUM 588 568 3 24
OMEPRAZOLE 561 533 4 8
NAMENDA 522 506 5 36
SIMVASTATIN 431 411 6 5
ESCITALOPRAM OXALATE 428 406 7 51
KLOR-CON M10 376 359 10 8 165
HYDROCODONE-ACETAMINOPHEN 375 336 S3 9 3
DONEPEZIL HCL 350 343 10 30
POTASSIUM CHLORIDE 340 326 11 11
SERTRALINE HCL 330 300 12 26
LANTUS 321 308 13 50
AMLODIPINE BESYLATE 301 281 14 1
EXELON 300 295 15 113
METFORMIN HCL 281 267 16 6
CARVEDILOL 278 272 17 22
RANITIDINE HCL 275 252 18 49
CITALOPRAM HBR 273 225 19 20
KLOR-CON M20 259 257 20 72
METOPROLOL TARTRATE 257 233 21 15
CRESTOR 250 207 22 25
LISINOPRIL 241 223 23 4
CLOPIDOGREL 228 215 24 28
IPRATROPIUM-ALBUTEROL 219 212 25 193
RISPERIDONE 210 195 26 78
QUETIAPINE FUMARATE 209 182 27 73
ZOLPIDEM TARTRATE 209 195 27 19
GABAPENTIN 205 170 29 12
TAMSULOSIN HCL 201 188 30 32
LEVOFLOXACIN 193 184 31 107
HYDROCHLOROTHIAZIDE 193 177 31 9
PLAVIX 182 176 33 42
DIOVAN 179 160 34 33
DIGOXIN 179 178 34 65
MEGESTROL ACETATE 175 168 R 36 92
DOXYCYCLINE HYCLATE 174 152 37 89
TRAMADOL HCL 171 163 38 16
NEXIUM 168 159 39 14
LIDODERM 167 166 40 227
PREDNISONE 158 151 41 47
POLYETHYLENE GLYCOL 3350 150 128 42 67
GLIMEPIRIDE 145 139 43 27
LEXAPRO 142 141 44 186
CLONIDINE HCL 140 129 45 35
ATORVASTATIN CALCIUM 139 139 46 13
CARBIDOPA-LEVODOPA 138 138 47 136
MECLIZINE HCL 137 125 48 97
CYMBALTA 136 136 49 45
NYSTATIN 132 124 50 173
NITROFURANTOIN MONO-MACRO 125 121 51 181
DILTIAZEM 24HR CD 125 125 51 156
FAMOTIDINE 125 91 51 90
SULFAMETHOXAZOLE-TRIMETHOPRIM 123 115 54 76
CEPHALEXIN 120 117 55 119
CLONIDINE 120 117 55 242
PHENYTOIN SODIUM EXTENDED 119 82 57 111
ISOSORBIDE MONONITRATE ER 119 119 57 60
KETOCONAZOLE 119 106 57 215
MIRTAZAPINE 117 88 60 82
SPIRONOLACTONE 114 113 61 85
OLANZAPINE 111 107 62 145
HYDROXYZINE PAMOATE 109 75 R 63 205
TRAZODONE HCL 107 92 64 40
ALBUTEROL SULFATE 106 100 65 162
NITROGLYCERIN PATCH 101 89 66 252
TRILIPIX 100 91 67 200
METOPROLOL SUCCINATE 100 84 67 17
PHENYTOIN 100 77 67 314
ALENDRONATE SODIUM 100 100 67 38
ADVAIR DISKUS 98 74 71 52
DEXAMETHASONE SODIUM PHOSPHATE 98 92 71 323
GLIPIZIDE 97 97 73 62
MUPIROCIN 97 95 73 121
NYSTATIN-TRIAMCINOLONE 96 92 75 277
NOVOLOG 93 92 76 178
VENLAFAXINE HCL ER 93 87 76 114
GENERLAC 93 81 76 330
PANTOPRAZOLE SODIUM 89 89 79 34
TRAVATAN Z 88 88 80 310
BISOPROLOL FUMARATE 87 87 81 163
NITROFURANTOIN 87 85 81 289
LYRICA 85 82 83 71
HYDROXYZINE HCL 85 82 R 83 200
DIVALPROEX SODIUM 83 80 85 126
SEROQUEL 80 69 86 167
FLUTICASONE PROPIONATE 73 72 87 39
FINASTERIDE 71 71 88 108
ROPINIROLE HCL 67 65 89 93
ENULOSE 66 54 90 402
MEGACE ES 66 65 R 90 353
LACTULOSE 65 65 92 112
MELOXICAM 65 65 92 18
ALLOPURINOL 65 58 92 31
SILVER SULFADIAZINE 64 64 95 406
BENAZEPRIL HCL 62 62 96 44
BETAMETHASONE DIPROPIONATE 61 56 97 358
CIPROFLOXACIN HCL 61 59 97 58
SOTALOL 60 48 99 269
DIOVAN HCT 60 60 99 48
FENTANYL 59 59 S2 101 151
PROMETHAZINE HCL 59 56 R 101 104
BENZTROPINE MESYLATE 57 51 R 103 196
NOVOLIN 70-30 57 56 103 199
PATADAY 55 42 105 235
SPIRIVA 55 52 105 66
OXYBUTYNIN CHLORIDE ER 55 49 105 154
ATENOLOL 54 48 108 23
HYDRALAZINE HCL 54 51 108 100
VALPROIC ACID 53 40 110 347
AMIODARONE HCL 52 52 111 206
NOVOLIN R 52 52 111 153
METOCLOPRAMIDE HCL 50 39 113 125
PRAVASTATIN SODIUM 50 43 113 10
ISOSORBIDE DINITRATE 50 50 113 281
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 31, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.